Skip to main content
SpringerPlus

Table 6 Independent risk factors associated with terlipressin-induced serum sodium reduction (> 5 mmol/L) in all patients

From: Initial serum sodium concentration determines the decrease in sodium level after terlipressin administration in patients with liver cirrhosis

 

p value

*OR

95% confidence interval [CI] for OR

   

Lower

Upper

Age

0.072

1.038

0.997

1.081

Sex

0.347

0.597

0.204

1.748

Purpose of use

0.746

1.423

0.168

12.019

Initial sodium (mmol/L)

0.000

1.299

1.131

1.493

Infusion of albumin

0.227

0.543

0.201

1.464

Child-Pugh score

0.229

0.844

0.639

1.113

Total bilirubin (mg/dL)

0.488

0.959

0.854

1078

Creatinine (mg/dL)

0.428

0.727

0.331

1.599

*MELD score

0.081

1.106

0.988

1.239

  1. *OR, Odds ratio; MELD, Model for end-stage liver disease.
Back to article page